Orthopedics and spine remains one of MedTech’s most established and high-volume sectors, addressing a global musculoskeletal disease burden affecting more than 1.71 billion people. Spanning joint reconstruction, spinal technologies, trauma, sports medicine, extremities, and enabling technologies, the sector continues to evolve through advances in robotics, surgical navigation, smart implants, and data-driven surgical workflows.
The global orthopedic devices market was valued at approximately $51.6 billion in 2024 and is projected to reach $68.5 billion by 2030, driven by ageing populations, increasing procedure volumes, and continued innovation across surgical technologies.
At the same time, the sector is undergoing significant transformation as the shift towards patient-specific implants, the standardization of robotic-assisted surgery and real-time navigation are reshaping how procedures are delivered and reimbursed. The migration of orthopedic procedures toward Ambulatory Surgical Centers (ASCs) is reshaping commercial strategies across MedTech. Leading companies such as Zimmer Biomet are expanding their outpatient presence through dedicated ASC solutions, combining implants, robotics, digital technologies, and infrastructure partnerships designed to support the shift toward same-day surgical care.
Securing leaders who grasp both traditional market dynamics and the strategic shifts redefining the sector requires a thorough, relationship-driven approach.